Immunogenicity and safety of different dose schedules and antigen doses of an MF59-adjuvanted H7N9 vaccine in healthy adults aged 65 years and older
在65岁及以上健康成年人中,不同剂量方案和抗原剂量的MF59佐剂H7N9疫苗的免疫原性和安全性
期刊:
影响因子:
doi:10.1016/j.vaccine.2020.11.051
Winokur, Patricia; El Sahly, Hana M; Mulligan, Mark J; Frey, Sharon E; Rupp, Richard; Anderson, Evan J; Edwards, Kathryn M; Bernstein, David I; Schmader, Kenneth; Jackson, Lisa A; Chen, Wilbur H; Hill, Heather; Bellamy, Abigail